(79 days)
Not Found
No
The device description focuses on mechanical compression and reprocessing of existing devices. There is no mention of AI/ML terms, image processing, or data sets for training/testing.
Yes
The device is intended to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE), indicating a therapeutic purpose to prevent or treat medical conditions.
No
The device, compression garments, are described as therapeutic devices that apply pressure to prevent blood pooling and DVT, not to diagnose a condition.
No
The device description clearly outlines physical components like compression garments, air compression pumps, sleeves, hoses, and connectors. The process described involves reprocessing these physical items.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The described device is a compression garment system that applies external pressure to the legs and feet to improve blood flow and prevent DVT. It is a physical therapy device, not a diagnostic test performed on a biological sample.
- Intended Use: The intended use is for prophylaxis (prevention) of DVT and PE, not for diagnosing these conditions.
- Device Description: The description focuses on the physical components and mechanism of action (inflation of sleeves), not on analyzing biological samples.
Therefore, this device falls under the category of a therapeutic or preventative medical device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
When coupled with an appropriate inflation system, compression garments are intended to increase venous return from the legs and feet as a prophylaxis for the formation of deep vein thrombosis (DVT) or subsequent pulmonary embolism (PE) in high risk and/or non-ambulatory patients. The compression garments are prescription devices intended for a single patient use only.
Product codes (comma separated list FDA assigned to the subject device)
JOW
Device Description
Compressible limb sleeves are devices that are used to prevent pooling of blood in a limb by inflating periodically a sleeve around the limb and increasing venous flow. Compression therapy is generally prescribed as a prophylaxis for deep vein thrombosis (DVT). The compression system consists of two primary pieces: an air compression pump and a soft, flexible sleeve in which the patient's extremity is placed. A hose to the pump connects to the sleeve, and when the pump is turned on, the air inflates the sleeve, applying a gentle pressure to the patient's extremity.
Compression garments consist of a non-woven fabric with “hook and loop” fasteners for attaching around the foot or leg. Air cells within the garment are molded to plastic hoses with connectors for attachment to the pump. The hoses and connectors are non-detachable and are reprocessed as part of the garment. Depending upon the original equipment manufacturer (OEM), garments may contain a single bladder and hose or multiple compartments and hoses that are sequentially pressurized.
Vanguard receives previously used compression garments from healthcare facilities; cleans, inspects, tests, repackages and sterilizes the garments; and returns them to the healthcare facility.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
legs and feet
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Decontamination and cleaning, packaging and sterilization validations and functional/performance and biocompatibility testing demonstrates that the reprocessed devices perform as intended and are safe and effective.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K781357, K863581, K890938, K932835, K942664, K992079, K881632, K961166, K932900, K944567, K981311, K955853, K964188, K974318, K000303
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.5800 Compressible limb sleeve.
(a)
Identification. A compressible limb sleeve is a device that is used to prevent pooling of blood in a limb by inflating periodically a sleeve around the limb.(b)
Classification. Class II (performance standards).
0
OCT 1 7 2001
:
K012403
Page 1 of 3
510(k) Summary of Safety & Effectiveness
| Submitter | Vanguard Medical Concepts, Inc.
5307 Great Oak Drive
Lakeland, FL 33815 |
|-------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact | Mr. Michael Sammon, Ph.D.
Director, Engineering
(863) 683-8680, extension 228
mikes@safe-reuse.com |
| Date | May 31, 2001 |
| Devices | Trade Names: Vanguard Reprocessed Compression Garments ⇒ Kendall SCD™ Sequential Compression Sleeves⇒ Kendall ImPad™ Rigid Sole Foot Covers⇒ Huntleigh Healthcare DVT Garments⇒ Aircast® VenaFlow® Cuffs⇒ Nutech®PlexiPulse® Wraps⇒ Healthcare Service & Supply ALP® Alternating Leg Pressure® GarmentsCommon Name: Compression garment, Compressible Limb SleeveClassification: 21 CFR 870.5800 – Compressible Limb Sleeve – Class IIProduct Code JOW |
| Predicate Devices | Kendall SCD™ Sequential Compression Sleeves and ImPad™ Rigid Sole Foot Covers believed to be legally marketed under various possible 510(k) premarket notifications (K781357, K863581, K890938, K932835, K942664, K992079)Huntleigh Healthcare DVT Garments believed to be legally marketed under a couple of possible 510(k) premarket notifications (K881632, K961166)Aircast® VenaFlow® Cuffs believed to be legally marketed under the possible 510(k) premarket notification K932900Nutech®PlexiPulse® Wraps believed to be legally marketed under a couple of possible 510(k) premarket notifications (K944567, K981311) |
| | Continued on next page |
1
Взегуз
510(k) Summary of Safety & Effectiveness, Continued
| Predicate Devices, continued | Healthcare Service & Supply ALP® Alternating Leg Pressure® Garments believed to be legally marketed under various possible 510(k) premarket notifications (K955853, K964188, K974318, K000303) |
|---|---|
| Indications for Use | When coupled with an appropriate inflation system, compression garments are intended to increase venous return from the legs and feet as a prophylaxis for the formation of deep vein thrombosis (DVT) or subsequent pulmonary embolism (PE) in high risk and/or non-ambulatory patients. The compression garments are prescription devices intended for a single patient use only. |
| Device Description | Compressible limb sleeves are devices that are used to prevent pooling of blood in a limb by inflating periodically a sleeve around the limb and increasing venous flow. Compression therapy is generally prescribed as a prophylaxis for deep vein thrombosis (DVT). The compression system consists of two primary pieces: an air compression pump and a soft, flexible sleeve in which the patient's extremity is placed. A hose to the pump connects to the sleeve, and when the pump is turned on, the air inflates the sleeve, applying a gentle pressure to the patient's extremity. |
| Compression garments consist of a non-woven fabric with “hook and loop” fasteners for attaching around the foot or leg. Air cells within the garment are molded to plastic hoses with connectors for attachment to the pump. The hoses and connectors are non-detachable and are reprocessed as part of the garment. Depending upon the original equipment manufacturer (OEM), garments may contain a single bladder and hose or multiple compartments and hoses that are sequentially pressurized. | |
| Vanguard receives previously used compression garments from healthcare facilities; cleans, inspects, tests, repackages and sterilizes the garments; and returns them to the healthcare facility. | |
| Continued on next page |
2
K 012403
Page 3 of 3
510(k) Summary of Safety & Effectiveness, Continued
| Technological
| Characteristics | The Vanguard reprocessed compression garments are essentially identical to the currently marketed OEM compression garments. No changes are made to the currently marketed devices' specifications (with the exception of sterility) and they possess the same technological characteristics. The OEM devices are marketed as non-sterile. As requested by customers, the Vanguard reprocessed devices are sterilized. Ethylene oxide gas is utilized and the sterilization validation demonstrates that sterility is achieved to a 10 -6 assurance level. Post-sterilization biocompatibility and performance/functional testing also demonstrate that the devices continue to be safe and effective for their intended use. |
|---|---|
| Test Data | Decontamination and cleaning, packaging and sterilization validations and functional/performance and biocompatibility testing demonstrates that the reprocessed devices perform as intended and are safe and effective. |
| Conclusion | Based on the information provided herein and the 510(k) "Substantial Equivalence" Decision Making Process Chart, we conclude that the Vanguard reprocessed compression garments are substantially equivalent to the predicate devices, the respective OEM compression garments under the Federal Food, Drug and Cosmetic Act. |
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/2 description: The image is a black and white circular logo. The logo features a stylized image of an eagle with its wings spread, and the silhouette of two human faces in profile. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the upper perimeter of the circle.
OCT 1 7 2001
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Michael Sammon, Ph.D. Director, Engineering Vanguard Medical Concepts, Inc. 5307 Great Oaks Drive Lakeland, FL 33815
Re: K012403
Trade Name: Vanguard Reprocessed Compression Garment Regulation Number: 21 CFR 870.5800 Regulation Name: Compressible Limb Sleeve Regulatory Class: Class II (two) Product Code: JOW Dated: May 31, 2001 Received: July 30, 2001
Dear Dr. Sammon:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for the barresor to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Michael Sammon, Ph.D.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
K. Dillard III
James E. Dillard III Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number: Kol2403
Device Name: Vanguard Reprocessed Compression Garments
Indications for Use:
When coupled with an appropriate inflation system, compression garments are intended to When coupled with an appropriate innution of sea prophylaxis for the formation of deep vein increase venous relum from the legs and leve a proprifican high risk and/or non-ambulatory thromboss (DV I ) of Subscquent pumblical ( encommand ( = )
patients. The compression garments are prescription devices intended for a single patient use only.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED.) IF NEEDED.)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use_ (Per 21 CFR 801.109)
:
.
OR
Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________
(Optional Format 1-2-96)
kh
Division of Cardiovascular & Respiratory Devices
of Cardiovascular & Respi
510(k) Number K02403
iv